Clinical Trials Logo

Acute Mania clinical trials

View clinical trials related to Acute Mania.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03287869 Completed - Bipolar I Disorder Clinical Trials

A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder.

Start date: October 24, 2017
Phase: Phase 3
Study type: Interventional

This study evaluated the safety and evaluate the safety and tolerability of open-label brexpiprazole (2 - 4 mg/day, with a starting dose of 2 mg/day) for the treatment of adult subjects with bipolar I disorder. All participants received a starting dose of brexpiprazole.

NCT ID: NCT00931723 Completed - Acute Mania Clinical Trials

Adult Bipolar Mania

Start date: June 2009
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine if lithium 600-1800 mg/day is effective when added to quetiapine fumarate extended release (quetiapine XR or SEROQUEL® XR) 400-800 mg/day in treating acute mania and if so, how it compares with placebo (a non-active capsule, like a sugar pill, that looks like lithium).